Unknown

Dataset Information

0

Atrial fibrillation as a marker of occult cancer.


ABSTRACT:

Background

Recent studies suggest that cancer increases risk of atrial fibrillation. Whether atrial fibrillation is a marker for underlying occult cancer is unknown.

Methods

We conducted a cohort study (1980-2011) of all Danish patients with new-onset atrial fibrillation. To examine cancer risk, we computed absolute risk at 3 months and standardized incidence ratios (SIRs) by comparing observed cancer incidence among patients newly diagnosed with atrial fibrillation with that expected based on national cancer incidence during the period.

Results

Median follow-up time was 3.4 years among 269 742 atrial fibrillation patients. Within 3 months of follow-up, 6656 cancers occurred (absolute risk, 2.5%; 95% confidence intervals [CI], 2.4%-2.5%) versus 1302 expected, yielding a SIR of 5.11; 95% CI, 4.99-5.24. Associations were particularly strong for cancers of the lung, kidney, colon, ovary, and for non-Hodgkin's lymphoma. The SIR within 3 months of follow-up was 7.02; 95% CI, 6.76-7.28 for metastatic and 3.53; 95% CI, 3.38-3.68 for localized cancer. Beyond 3 months of follow-up, overall cancer risk was modestly increased (SIR, 1.13; 95% CI, 1.12-1.15).

Conclusion

Patients with new-onset atrial fibrillation had a markedly increased relative risk of a cancer diagnosis within the next three months, however, corresponding absolute risk was small.

SUBMITTER: Ostenfeld EB 

PROVIDER: S-EPMC4138009 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Atrial fibrillation as a marker of occult cancer.

Ostenfeld Eva B EB   Erichsen Rune R   Pedersen Lars L   Farkas Dóra K DK   Weiss Noel S NS   Sørensen Henrik T HT  

PloS one 20140813 8


<h4>Background</h4>Recent studies suggest that cancer increases risk of atrial fibrillation. Whether atrial fibrillation is a marker for underlying occult cancer is unknown.<h4>Methods</h4>We conducted a cohort study (1980-2011) of all Danish patients with new-onset atrial fibrillation. To examine cancer risk, we computed absolute risk at 3 months and standardized incidence ratios (SIRs) by comparing observed cancer incidence among patients newly diagnosed with atrial fibrillation with that expe  ...[more]

Similar Datasets

| S-EPMC11016113 | biostudies-literature
| S-EPMC6489979 | biostudies-literature
| S-EPMC8922535 | biostudies-literature
| 2312263 | ecrin-mdr-crc
| S-EPMC9733955 | biostudies-literature
| S-EPMC10043201 | biostudies-literature
| S-EPMC10064848 | biostudies-literature
| S-EPMC11612213 | biostudies-literature
2020-04-01 | GSE139427 | GEO
| S-EPMC11561269 | biostudies-literature